Nektar Therapeutics
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2017 | $24.7M | $-54.4M | $-63.9M |
| Jun 2017 | $34.6M | $-50.7M | $-59.9M |
| Sep 2017 | $152.9M | $69.5M | $60.9M |
| Dec 2017 | $95.5M | $-24.0M | $-33.8M |
| Mar 2018 | $38.0M | $-86.7M | $-95.8M |
| Jun 2018 | $1.09B | $973.6M | $971.5M |
| Sep 2018 | $27.8M | $-98.6M | $-96.1M |
| Dec 2018 | $39.8M | $-100.3M | $-98.2M |
| Mar 2019 | $28.2M | $-120.7M | $-119.6M |
| Jun 2019 | $23.3M | $-111.0M | $-110.3M |
| Sep 2019 | $29.2M | $-98.7M | $-98.6M |
| Dec 2019 | $33.9M | $-109.6M | $-112.2M |
| Mar 2020 | $50.6M | $-133.6M | $-138.7M |
| Jun 2020 | $48.8M | $-77.7M | $-80.0M |
| Sep 2020 | $30.0M | $-103.1M | $-108.6M |
| Dec 2020 | $23.5M | $-110.7M | $-117.2M |
| Mar 2021 | $23.6M | $-109.4M | $-123.0M |
| Jun 2021 | $28.3M | $-110.2M | $-125.5M |
| Sep 2021 | $24.9M | $-113.6M | $-129.7M |
| Dec 2021 | $25.0M | $-112.9M | $-145.6M |
| Mar 2022 | $24.8M | $-116.6M | $-90.4M |
| Jun 2022 | $21.6M | $-152.8M | $-159.1M |
| Sep 2022 | $23.6M | $-54.3M | $-59.0M |
| Mar 2023 | $21.6M | $-134.7M | $-137.0M |
| Jun 2023 | $20.5M | $-50.6M | $-51.1M |
| Sep 2023 | $24.1M | $-44.9M | $-45.8M |
| Mar 2024 | $21.6M | $-35.4M | $-36.8M |
| Jun 2024 | $23.5M | $-49.8M | $-52.4M |
| Sep 2024 | $24.1M | $-34.3M | $-37.1M |
| Mar 2025 | $10.5M | $-44.5M | $-50.9M |
| Jun 2025 | $11.2M | $-36.2M | $-41.6M |
| Sep 2025 | $11.8M | $-31.7M | $-35.5M |
| Mar 2026 | $10.9M | $-39.1M | $-44.9M |
| Jun 2026 | $10.1M | $-42.3M | $-40.6M |